The Food and Drug Administration has approved a new indication for Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) oral pellets. The drug now is indicated to treat children ages 3 months to less ...

Abstract sphere from a blood clot cells background. Scientific and medical microbiological concept. Enrichment with oxygen and important nutrients. Transfer of important elements, 3d illustration ...

RIDGEFIELD, Conn., April 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa ® (dabigatran ...

Pradaxa label updated with contraindication The anticoagulant dabigatran etexilate mesylate should not be used in patients with mechanical prosthetic heart valves, the FDA warns. HealthDay News – The ...

Dec 7 (Reuters) - U.S. health regulator said it was evaluating reports of serious bleeding events in patients taking German drugmaker Boehringer Ingelheim's new stroke prevention pill Pradaxa, but ...

Alembic has received the Food and Drug Administration’s permission for Dabigatran Etexilate Capsules, 75 mg and 150 mg and tentative approval for Dabigatran Etexilate Capsules, 110 mg. The approved ...

Scientists say they're close to having a treatment that can quickly reverse the effects of the anti-clotting drug Pradaxa when necessary. Pradaxa is a new kind of blood thinner. It was approved by the ...

The FINANCIAL — Boehringer Ingelheim GmbH announced the U.S. Food and Drug Administration (FDA) granted approval of Praxbind (idarucizumab). Praxbind is indicated for patients treated with Pradaxa ...

LONDON, Aug 17 (Reuters) - Britain's healthcare cost-effectiveness watchdog has demanded more information on Boehringer Ingelheim's new anti-clotting pill Pradaxa before deciding whether to recommend ...

RICHMOND, Va. — The Fourth Circuit found the pharmaceutical company that makes Pradaxa, a drug to reduce the risk of stroke, cannot be sued for a woman's death after she suffered a gastrointestinal ...